Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huma Q Rana

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
BMC Cancer|February 23, 2019
Are rare cancer survivors at elevated risk of subsequent new cancers?Dianne M Finkelstein, Nora K Horick, Ritesh Ramchandani, et al.
European Urology Oncology|February 17, 2026
Expanding Risk-adapted Early Detection of Prostate Cancer: A Call to Action for Men at High RiskMaike K Klett, Peter Albers, Adam Kibel, et al.
Cancer|December 7, 2021
Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristicsBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Breast Cancer Research and Treatment|May 13, 2023
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Breast Cancer Research and Treatment|March 1, 2023
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2026
The biology of hypomorphic TP53 variants and implications for clinical managementRenyta Moses, Jacquelyn Powers, Alison S Levine, et al.
Data in Brief|December 22, 2021
Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic dataDanielle K Manning, Priyanka Shivdasani, Diane R Koeller, et al.
JCO Precision Oncology|January 7, 2022
Evaluation of <i>TP53</i> Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic <i>TP53</i> VariantsAlison N Schwartz, Sophie R Hyman, Samantha M Stokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
Low allele frequency variants identified on germline multi-gene panel testing for cancer predisposition can suggest the presence of constitutional mosaicismAdela Rodriguez-Hernandez, Linda M Polfus, Brittany L Bychkovsky, et al.
Cancer Genetics|November 11, 2022
Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer FamilyNihat Bugra Agaoglu, Ozden Hatirnaz Ng, Busra Unal, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
BMC Cancer|February 23, 2019
Are rare cancer survivors at elevated risk of subsequent new cancers?Dianne M Finkelstein, Nora K Horick, Ritesh Ramchandani, et al.
European Urology Oncology|February 17, 2026
Expanding Risk-adapted Early Detection of Prostate Cancer: A Call to Action for Men at High RiskMaike K Klett, Peter Albers, Adam Kibel, et al.
Cancer|December 7, 2021
Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristicsBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Breast Cancer Research and Treatment|May 13, 2023
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Breast Cancer Research and Treatment|March 1, 2023
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interceptionBrittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2026
The biology of hypomorphic TP53 variants and implications for clinical managementRenyta Moses, Jacquelyn Powers, Alison S Levine, et al.
Data in Brief|December 22, 2021
Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic dataDanielle K Manning, Priyanka Shivdasani, Diane R Koeller, et al.
JCO Precision Oncology|January 7, 2022
Evaluation of <i>TP53</i> Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic <i>TP53</i> VariantsAlison N Schwartz, Sophie R Hyman, Samantha M Stokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
Low allele frequency variants identified on germline multi-gene panel testing for cancer predisposition can suggest the presence of constitutional mosaicismAdela Rodriguez-Hernandez, Linda M Polfus, Brittany L Bychkovsky, et al.
Cancer Genetics|November 11, 2022
Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer FamilyNihat Bugra Agaoglu, Ozden Hatirnaz Ng, Busra Unal, et al.
Pageof 8